TheJournalofMusculoskeletalMedicine Members: Login | Register
TheJournalofMusculoskeletalMedicine SearchMedica Medline Drugs

Powered by SearchMedica

 
Conferences
News
In the Journals
Gout
Osteoarthritis
Osteoporosis
Rheumatoid Arthritis
Multimedia
Photo Quiz
 


 

First Polymyalgia Rheumatica Classification Criteria Released

March 21, 2012

The first-ever classification criteria for polymyalgia rheumatica (PMR), a common cause of widespread pain and stiffness in older patients, are designed to help physicians better identify patients who have this condition. The new criteria were released by the American College of Rheumatology (ACR) in collaboration with The European League Against Rheumatism.

The diagnosis of PMR often is difficult because the condition rarely causes swollen joints or other abnormalities that can be seen on a physical examination and there have been no well established criteria to recognize it, the ACR noted. The pain and stiffness associated with PMR are common symptoms caused by other illnesses in older persons, and there is a lack of standardized testing to confirm the disease, minimal scientific research evaluating therapies, and an absence of genetic markers to identify disease risk.

(MORE: The Sydney Classification Criteria for Definite Antiphospholipid Syndrome)

The new criteria for PMR will improve recognition by defining the disease features that are useful in classifying patients' symptoms. They also provide a structure that will facilitate a better understanding of the disease and its course and the development of new therapies and clinical trials.

Under the new criteria, patients aged 50 years and older may be classified as having PMR if they meet all of the following conditions:
• Shoulder pain on both sides.
• Morning stiffness that lasts at least 45 minutes.
• High levels of inflammation measured by protein in the blood and erythrocyte sedimentation rate.
• Reported new hip pain.
• An absence of swelling in the small joints of the hands and feet and an absence of positive blood test results for rheumatoid arthritis.

The new classification criteria also may help evaluate existing treatments for patients with PMR. However, they were created to provide guidance and not for diagnostic purposes, it was noted.

For more information, visit the ACR Web site at http://www.rheumatology.org. Or, contact the organization at American College of Rheumatology, 2200 Lake Boulevard NE, Atlanta, GA 30319; telephone: (404) 633-3777; fax (404) 633-1870.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Related Articles

Lupus Nephritis–Specific Management Guidelines Issued

Updated Recommendations for Hand, Hip, and Knee Osteoarthritis Therapy

The Sydney Classification Criteria for Definite Antiphospholipid Syndrome

First Polymyalgia Rheumatica Classification Criteria Released






 
TOPIC INDEX

  • Arthritis
  • Fibromyalgia
  • Geriatrics
  • Gout
  • Imaging
  • Juvenile Arthritis
  • Lupus
  • Osteoarthritis
  • Osteoporosis
  • Pain
  • Rheumatoid Arthritis
  • Women


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent

  • Iontophoretic Administration of Dexamethasone for Musculoskeletal Pain
  • Managing degenerative lumbar spinal stenosis
  • Evaluating edema of the hands
  • Iliopsoas Bursitis
  • Rash Questions for Rheumatologists
  • Diagnosis and Management of Complex Regional Pain Syndrome
  • Botox Adds New Wrinkle to Debated Hyaluronic Acid Treatments for Knee OA
  • OARSI Adopts Tests for Physical Function in Hip and Knee OA
  • International Consensus on Treatment Targets for Spondyloarthritis and Psoriatic Arthritis
  • In Primary Sjögrens, Hydroxychloroquine Ineffective in Short-Term
  • Granulomatosis With Polyangiitis, With Atypical Features
  • Man With Chest and Shoulder Pain, Cough, and Mediastinal Mass
  • Rheumatology Network PhotoQuiz Contest OFFICIAL RULES
  • Azathioprine Not Linked to Flare Risk in Lupus Nephritis Pregnancies
  • Methotrexate Failures in RA, Ustekinumab Success in PsA, and Mood-Immunity Links
Click here to subscribe to our newsletter





CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy